|
1
|
Magnano LC, Martínez Cibrian N, Andrade
González X and Bosch X: Cardiac complications of chemotherapy: Role
of prevention. Curr Treat Options Cardiovasc Med. 16:3122014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jang WJ, Choi DY and Jeon IS: Vascular
endothelial dysfunction after anthracyclines treatment in children
with acute lymphoblastic leukemia. Korean J Pediatr. 56:130–134.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Truong J, Yan AT, Cramarossa G and Chan
KK: Chemotherapy-induced cardiotoxicity: detection, prevention and
management. Can J Cardiol. 30:869–878. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Spagnuolo RD, Recalcati S, Tacchini L and
Cairo G: Role of hypoxia-inducible factors in the
dexrazoxane-mediated protection of cardiomyocytes from
doxorubicin-induced toxicity. Br J Pharmacol. 163:299–312. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Klotz LO, Sánchez-Ramos C, Prieto-Arroyo
I, Urbánek P, Steinbrenner H and Monsalve M: Redox regulation of
FoxO transcription factors. Redox Biol. 6:51–72. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu MH, Yuan C, He J, Tan TP, Wu SJ, Fu
HY, Liu J, Yu S, Chen YD, Le QF, et al: Resveratrol protects PC12
cells from high Glucose-induced neurotoxicity via PI3K/Akt/FoxO3a
pathway. Cell Mol Neurobiol. 35:513–522. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fiuza B, Subelzú N, Calcerrada P,
Straliotto MR, Piacenza L, Cassina A, Rocha JB, Radi R, de Bem AF
and Peluffo G: Impact of SIN-1-derived peroxynitrite flux on
endothelial cell redox homeostasis and bioenergetics: Protective
role of diphenyl diselenide via induction of peroxiredoxins. Free
Radic Res. 49:122–132. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Poynton RA and Hampton MB: Peroxiredoxins
as biomarkers of oxidative stress. Biochim Biophys Acta.
1840:906–912. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jeong HJ, Jeong HW, Song SS, Kang JW, Seo
JH, Lee YH, Lee KS and Kim DW: Upregulation of peroxiredeoxin III
in the hippocampus of acute immobilization stress model rats and
the Foxo3a-dependent expression in PC12 cells. Cell Mol Neurobiol.
31:1041–1046. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chae HZ, Kim HJ, Kang SW and Rhee SG:
Characterization of three isoforms of mammalian peroxiredoxin that
reduce peroxides in the presence of thioredoxin. Diabetes Res Clin
Pract. 45:101–112. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Matsushima S, Ide T, Yamato M, Matsusaka
H, Hattori F, Ikeuchi M, Kubota T, Sunagawa K, Hasegawa Y, Kurihara
T, et al: Overexpression of mitochondrial peroxiredoxin-3 prevents
left ventricular remodeling and failure after myocardial infarction
in mice. Circulation. 113:1779–1786. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chang TS, Cho CS, Park S, Yu S, Kang SW
and Rhee SG: Peroxiredoxin III, a mitochondrion-specific
peroxidase, regulates apoptotic signaling by mitochondria. J Biol
Chem. 279:41975–41984. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chiribau CB, Cheng L, Cucoranu IC, Yu YS,
Clempus RE and Sorescu D: FOXO3A regulates peroxiredoxin III
expression in human cardiac fibroblasts. J Biol Chem.
283:8211–8217. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lipshultz SE, Karnik R, Sambatakos P,
Franco VI, Ross SW and Miller TL: Anthracycline-related
cardiotoxicity in childhood cancer survivors. Curr Opin Cardiol.
29:103–112. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Salazar-Mendiguchía J, González-Costello
J, Roca J, Ariza-Sole A, Manito N and Cequier A:
Anthracycline-mediated cardiomyopathy: Basic molecular knowledge
for the cardiologist. Arch Cardiol Mex. 84:218–223. 2014.PubMed/NCBI
|
|
16
|
Song IS, Kim HK, Jeong SH, Lee SR, Kim N,
Rhee BD, Ko KS and Han J: Mitochondrial peroxiredoxin III is a
potential target for cancer therapy. Int J Mol Sci. 12:7163–7185.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hattori F, Murayama N, Noshita T and
Oikawa S: Mitochondrial peroxiredoxin-3 protects hippocampal
neurons from excitotoxic injury in vivo. J Neurochem. 86:860–868.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Betge S, Lutz K, Roskos M and Figulla HR:
Oral treatment with probucol in a pharmacological dose has no
beneficial effects on mortality in chronic ischemic heart failure
after large myocardial infarction in rats. Eur J Pharmacol.
558:119–127. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xi L, Zhu SG, Hobbs DC and Kukreja RC:
Identification of protein targets underlying dietary
nitrate-induced protection against doxorubicin cardiotoxicity. J
Cell Mol Med. 15:2512–2524. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Storz P: Forkhead homeobox type O
transcription factors in the responses to oxidative stress.
Antioxid Redox Signal. 14:593–605. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pierrou S, Hellqvist M, Samuelsson L,
Enerbäck S and Carlsson P: Cloning and characterization of seven
human forkhead proteins: binding site specificity and DNA bending.
EMBO J. 13:5002–5012. 1994.PubMed/NCBI
|
|
22
|
Schwarzer M, Osterholt M, Lunkenbein A,
Schrepper A, Amorim P and Doenst T: Mitochondrial reactive oxygen
species production and respiratory complex activity in rats with
pressure overload-induced heart failure. J Physiol. 592:3767–3782.
2014. View Article : Google Scholar : PubMed/NCBI
|
